Apparo Inc. announces funding that will support the development and commercialization of its sunflower protein ingredients

Article

Apparo Inc. has announced a Series A investment of $3.5 million co-led by Endeavor8 and Finistere Ventures, and joined by Blue Horizon.

 Photo © AdobeStock.com/Sergii Figurnyi

Photo © AdobeStock.com/Sergii Figurnyi

Apparo Inc. (Eden Prairie, MN) has announced a Series A investment of $3.5 million co-led by Endeavor8 and Finistere Ventures, and joined by Blue Horizon, to support its development of sunflower protein ingredients incorporating Apparo’s Total Crop Utilization system. The system applies Apparo’s patent-pending technology to extract sunflower protein ingredients in order to meet the rising demands of the rapidly growing plant-based protein food market.

“At least 200,000 tons of plant protein ingredients are needed to reach the 2026 market demand, which is a huge opportunity for new sources of protein ingredients, particularly highly functional native proteins such as our Solistein sunflower protein isolate,” said Ian Mackay, CEO of Apparo, in a press release. “With two successful co-manufacturing trials for our Solistein ingredients, our experienced team is now poised for a rapid ramp up of the commercialization of our products.”

Apparo’s technology utilizes existing crop byproducts as a feedstock to create its Solistein protein ingredients. According to the company, it also allows Apparo to narrow the protein gap without additional impact to the environment.

Recent Videos
woman working on laptop computer by window
Related Content
© 2024 MJH Life Sciences

All rights reserved.